Finance
Market Analysts see VBI Vaccines Inc. [VBIV] falling to $2. Time to buy?
VBI Vaccines Inc. [NASDAQ: VBIV] slipped around -0.26 points on Tuesday, while shares priced at $0.66 at the close of the session, down -28.34%. The company report on April 9, 2024 at 2:45 PM that VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market
